Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2006-5-17
pubmed:abstractText
The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1537-6591
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e108-10
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Rhabdomyolysis during therapy with daptomycin.
pubmed:affiliation
Department of Pharmacy, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536, USA. spapa2@email.uky.edu
pubmed:publicationType
Journal Article, Case Reports